Alphamab's anbenitamab shows promise in gastric cancer trial
Alphamab Oncology's anbenitamab significantly improved PFS and OS in HER2-positive gastric cancer patients in a phase III trial, published in Annals of Oncology.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.